Erasmus Universiteit Rotterdam, Institute for Medical Technology Assessment, PO Box 1738, 3000 DR Rotterdam, The Netherlands.
J Neurooncol. 2011 Jan;101(2):237-45. doi: 10.1007/s11060-010-0243-4. Epub 2010 Jun 6.
The aim of the present study is to determine and compare initial treatment costs of microsurgery, linear accelerator (LINAC) radiosurgery, and gamma knife radiosurgery in meningioma patients. Additionally, the follow-up costs in the first year after initial treatment were assessed. Cost analyses were performed at two neurosurgical departments in The Netherlands from the healthcare providers' perspective. A total of 59 patients were included, of whom 18 underwent microsurgery, 15 underwent LINAC radiosurgery, and 26 underwent gamma knife radiosurgery. A standardized microcosting methodology was employed to ensure that the identified cost differences would reflect only actual cost differences. Initial treatment costs, using equipment costs per fraction, were
本研究旨在确定和比较脑膜瘤患者显微手术、线性加速器(LINAC)放射外科和伽玛刀放射外科的初始治疗成本,并评估初始治疗后第一年的随访成本。成本分析在荷兰的两个神经外科部门从医疗保健提供者的角度进行。共纳入 59 例患者,其中 18 例行显微手术,15 例行 LINAC 放射外科,26 例行伽玛刀放射外科。采用标准化微成本核算方法,以确保确定的成本差异仅反映实际成本差异。使用每部分设备成本计算初始治疗成本,显微手术为<欧元>12288,LINAC 放射外科为<欧元>1547,伽玛刀放射外科为<欧元>2412。显微手术初始治疗成本较高,主要是由于住院费用(<欧元>5321)和间接成本(<欧元>4350)较高。当设备按治疗次数计价时,LINAC 和伽玛刀放射外科的成本相同(分别为<欧元>2198 和<欧元>2412)。与 LINAC 和伽玛刀放射外科相比,显微手术的随访成本略高,但无统计学意义。尽管与两种放射外科治疗相比,显微手术的初始治疗成本高出五倍以上,但我们的研究表明,当纳入初始治疗后第一年发生的随访成本时,相对成本差异可能会降低。这强调了在比较替代治疗方案的相对成本时,需要考虑初始治疗后的随访成本。